Skip to primary navigation Skip to main content
Buffalo Local Index
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Avinger Inc (NQ: AVGR)
0.4389 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 7:57 PM EST, Feb 15, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open -
Bid (Size) 0.4250 (49)
Ask (Size) 0.4300 (5)
Prev. Close 0.4389
Today's Range 0.4389 - 0.4389
52wk Range 0.1800 - 2.440
Shares Outstanding 9,068,372
Dividend Yield N/A
Performance
YTD
+56.75%
+56.75%
1 Month
+51.34%
+51.34%
3 Month
+46.30%
+46.30%
6 Month
-61.83%
-61.83%
1 Year
-70.74%
-70.74%
Top News
More News
Avinger’s Pantheris SV (Small Vessel) Featured in Live Case Transmission at Leipzig Interventional Course (LINC) 2019
Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that its Pantheris® SV (Small Vessel) image-guided atherectomy system was... Read More
from GlobeNewswire News Releases
Avinger Announces Preliminary Analysis of Results from SCAN Clinical Study
Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced the release of the preliminary analysis of results from its SCAN clinical... Read More
from GlobeNewswire News Releases
More News
Read More
Avinger Announces Successful Treatment of 500th Patient with Next-Generation Pantheris Device
from GlobeNewswire News Releases
Avinger Announces Commercial Launch in Australia
from GlobeNewswire News Releases
Market Trends Toward New Normal in Wilhelmina International, Eyenovia, aTyr Pharma, Avinger, Viacom, and Axsome Therapeutics — Emerging Consolidated Expectations, Analyst Ratings
from GlobeNewswire News Releases
Avinger Announces Successful Treatment of First Patients Globally with Pantheris SV, a New Image-Guided Atherectomy Device Designed to Treat Smaller Vessels
from ACCESSWIRE
Avinger Provides Third Quarter 2018 Shareholder Update
from ACCESSWIRE
Avinger to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum 2018
from ACCESSWIRE
Avinger to Announce Third Quarter 2018 Financial Results on November 13, 2018
from ACCESSWIRE
Avinger Announces Closing of $11.5 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
from ACCESSWIRE
Avinger Announces Pricing of $10 Million Underwritten Public Offering
from ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.